
Tumour-infiltrating lymphocytes (TILs) and cytokines are associated with prognosis among patients with head and neck squamous cell carcinoma (HNSCC). Statins (cholesterol‐lowering drugs) may improve HNSCC prognosis, particularly in human papillomavirus (HPV)‐positive cases, but the mechanism remains unclear. Statins may influence TILs in HPV‐positive patients. This may be how they improve prognosis in HPV‐positive HNSCC patients.
Like
Save
Share